Ersilia Fiscarelli
Overview
Explore the profile of Ersilia Fiscarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pariano M, Puccetti M, Stincardini C, Napolioni V, Gatticchi L, Galarini R, et al.
Am J Respir Cell Mol Biol
. 2022 Oct;
68(3):288-301.
PMID: 36252182
Hypoxia contributes to the exaggerated yet ineffective airway inflammation that fails to oppose infections in cystic fibrosis (CF). However, the potential for impairment of essential immune functions by HIF-1α (hypoxia-inducible...
2.
Papi M, Fiscarelli E
Int J Low Extrem Wounds
. 2022 May;
:15347346221102642.
PMID: 35585699
Visual art images narrate the evolution of humankind including different and specific wound managing strategies. Through the observation of some notable art works we explore the empiric historical progress in...
3.
Collalto D, Giallonardi G, Fortuna A, Meneghini C, Fiscarelli E, Visca P, et al.
Front Microbiol
. 2022 May;
13:845231.
PMID: 35547141
The chronic lung infection caused by is a major cause of morbidity and mortality in cystic fibrosis (CF) patients. Antivirulence drugs targeting quorum sensing (QS) systems are intensively studied as...
4.
Papi M, Fiscarelli E
Psych J
. 2021 Jan;
10(2):244-248.
PMID: 33434954
We report the interesting experience of the African Village of Hope (Dodoma, Tanzania) where HIV-positive orphan children have been hosted, cured, and educated in the last 15 years. The particular...
5.
Bacci G, Taccetti G, Dolce D, Armanini F, Segata N, Di Cesare F, et al.
Microorganisms
. 2020 Jul;
8(7).
PMID: 32635564
Although the cystic fibrosis (CF) lung microbiota has been characterized in several studies, little is still known about the temporal changes occurring at the whole microbiome level using untargeted metagenomic...
6.
Pompilio A, Savini V, Fiscarelli E, Gherardi G, Di Bonaventura G
Antibiotics (Basel)
. 2020 Jan;
9(1).
PMID: 31906465
The intrinsic antibiotic resistance of , along with its ability to form biofilm both on abiotic surfaces and host tissues, dramatically affects the efficacy of the antibiotic therapy. In this...
7.
Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, et al.
Front Immunol
. 2019 May;
10:890.
PMID: 31134053
is the causative agent of human diseases ranging from asthma to invasive infection. Genetic and environmental factors are crucial in regulating the interaction between the host and . The role...
8.
Gherardi G, Linardos G, Pompilio A, Fiscarelli E, Di Bonaventura G
Diagn Microbiol Infect Dis
. 2019 Feb;
94(3):297-303.
PMID: 30803726
The in vitro activity of ceftolozane-tazobactam (C-T) was evaluated comparatively to other antibiotics against 188 Pseudomonas aeruginosa isolates collected from cystic fibrosis (CF) patients. Overall, the activity of C-T was...
9.
Delhaes L, Touati K, Faure-Cognet O, Cornet M, Botterel F, Dannaoui E, et al.
J Cyst Fibros
. 2018 Oct;
18(2):212-220.
PMID: 30348610
No abstract available.
10.
DAngelo F, Baldelli V, Halliday N, Pantalone P, Polticelli F, Fiscarelli E, et al.
Antimicrob Agents Chemother
. 2018 Sep;
62(11).
PMID: 30201815
The long-term use of antibiotics has led to the emergence of multidrug-resistant bacteria. A promising strategy to combat bacterial infections aims at hampering their adaptability to the host environment without...